Furthermore, in a murine model of HCC on a background of fibrosis, the pharmacological inhibition of TAM recruitment via CCL2 showed a significant reduction in the extent of angiogenesis within tumours and, consequently, tumour progression, as measured by tumour volume [153]. This evidence concerns the gene CCL2 and neoplasm.